Figure 1.
BMP and TGF-β signaling define divergent molecular identities in glioblastoma. (A) H&E and IHC for pSmad1 (BMP) and pSmad2 (TGF-β) in human glioblastoma surgical specimens (n = 9). (B) Single-cell analysis of pSmad1- and pSmad2-positive cells isolated by laser capture microscopy. (C) Unsupervised clustering of single-cell glioblastoma RNA-seq data using the most variable genes. Cell identity was determined using cell markers for pSmad1 and pSmad2-positive glioma cells. (D) Log-normalized gene expression for selected genes is shown for the SMAD1(+) and SMAD2(+) glioma cell populations defined in 1 C. (E) Gene set enrichment analysis for genes upregulated in SMAD1(+) (left) and SMAD2(+) (right) glioma cell populations identified by analysis of single-cell glioblastoma RNA-seq data. (F) Quantification of PCNA-expression in pSmad1- and pSmad2-positive cells in human glioblastoma surgical specimens (n = 4, 15 HPF/specimen; *p < 0.05).